Home
Freedom Debt Relief News
Influenza Pandemic Links
Terms of Service
Sitemap

Navigation

Pig virus
Flu remedies
Tamiflu
Swine flu epidemic
Flu masks
Protect against swine flu
Flu vaccinations
Flu pandemic preparedness
Swine flu prevention
Flu symptoms
Swine flu scare
Flu protection
Swine flu vaccine
Pandemic planning
Swine flu help



FluSwine Recommended Products Online pharmacy for tamiflu for swine flu and books store


Influenza Pandemic Headlines

Seven Influenza Vaccines For Coming Season Approved By FDA

The US FDA (Food and Drug Administration) has approved vaccines for the 2010-2011 USA influenza season, protecting against three strains of influenza, including the H1N1 virus which caused the 2009 pandemic. In 2009, because the H1N1 virus appeared after seasonal vaccine production commenced, two separate vaccines were required to protect against the seasonal flu and the 2009 H1N1 pandemic flu ...

Read more...


Pandemic Influenza H1N1 2009 (swine flu) No. 197

Click for big version Weekly consultation rates for influenza-like illness in New Zealand, 2008-2010 Source: Institute of Environmental Science and Research, Influenza Weekly Update 2010/28

Read more...


Swine Flu Pandemic Hit Children the Hardest

Title: Swine Flu Pandemic Hit Children the Hardest Category: Health News Created: 7/30/2010 10:51:00 AM Last Editorial Review: 7/30/2010 10:51:31 AM

Read more...


FDA Approves Vaccines For The 2010-2011 Influenza Season

The U.S. Food and Drug Administration announced that it has approved vaccines for the 2010-2011 influenza season in the United States. Seasonal influenza vaccine protects against three strains of influenza, including the 2009 H1N1 influenza virus, which caused the 2009 pandemic. Last year because the 2009 H1N1 virus emerged after production began on the seasonal vaccine, two separate vaccines ...

Read more...


Novavax receives US patent for influenza virus-like particles

Novavax, Inc. announced the issuance of US Patent No. 7,763,450 for Functional Influenza Virus-Like Particles (VLPS). The patent covers the use of influenza gene sequences for high-yield production of consistent influenza VLP vaccines to protect against current and future seasonal and pandemic strains of influenza viruses.

Read more...